U.S. Food and Drug Administration Approves POMALYST® (pomalidomide) for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma | View photo - Yahoo! Finance

previous $U.S. Food and Drug Administration Approves POMALYST® (pomalidomide) for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma$ next

Fri, Feb 8, 2013 9:09 PM EST

POMALYST(R) brand therapy (Photo: Business Wire)Multimedia Gallery URL

Latest Photos

Today on Yahoo!